Search within Hartington Pharmaceutical website

Intranet

Contact

Our goal is to provide patients with high-quality product in the shortest time possible. Out-licensing reduces our time-to-market, ensuring that the therapies of the future reach those who need them most.

The following out-licensing opportunities are currently available:

Product: Nasodren® - Medical Device Class I

Indication:

- Acute or chronic recurrent inflammation of the para nasal sinuses (rhinosinusitis): catarrhal or purulent maxillary rhinosinusitis, frontitis, ethmoiditis, sphenoiditis, or combined rhinosinusitis.

- Acute purulent rhinosinusitis, accompanied by generalized infection or orbital complications.

- In case of orbital complications or generalized infection, NASODREN® should be administered in combination with antibiotics.

- Acute exudative or purulent otitis media, chronic exudative, acute secretory otitis media or purulent otitis media. In case of fever, Nasodren® should be administered in combination with antibiotics.

- In postoperative care, after nasal or nasosinusal surgery.

For more details please contact us:

e-mail: info@hartington.org